Estimate Recalculated Nov 1, 2024 10:46AM EST
Scott Andrew Smith has an estimated net worth of $7.45 Million. This is based on reported shares across multiple companies, which include BioAtla, Inc., Spring Bank Pharmaceuticals, Inc., Viatris Inc, Apexigen, Inc., TITAN PHARMACEUTICALS INC, and CELGENE CORP /DE/.
Scott Andrew Smith's CIK is 0001614975
2015 was Scott Andrew Smith's most active year for acquiring shares with 9 total transactions. Scott Andrew Smith's most active month to acquire stocks was the month of November. 2021 was Scott Andrew Smith's most active year for disposing of shares, totalling 19 transactions. Scott Andrew Smith's most active month to dispose stocks was the month of November. 2019 saw Scott Andrew Smith paying a total of $49,080.00 for 44,976 shares, this is the most they've acquired in one year. In 2021 Scott Andrew Smith cashed out on 45,201 shares for a total of $1,622,635.30, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!